Wednesday, 17 April 2024
Arbutus Biopharma Corporation
NASDAQ : ABUS
2.190
14 Oct 22 00:00 | Change:
 0.10 | Open:
2.100 | High:
2.200 | Ask:
0.000 | Volume:
3,061,700 |
Change(%):
4.78 | Prev:
2.090 | Low:
2.100 | Bid:
0.000 | Avg vol:
0 |
Analysts expect Arbutus Biopharma Corporation (NASDAQ:ABUS) to report $-0.38 EPS on March, 20.They anticipate $0.00 EPS change or 0.00 % from last quarter's $-0.38 EPS.
more»14:52 | 5/3/18
Danvers Record
Arbutus Biopharma Corporation (NasdaqGS:ABUS) currently has a current ratio of 11.03. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to the ...
more»13:11 | 3/3/18
Frisco Fastball
Analysts expect Arbutus Biopharma Corporation (NASDAQ:ABUS) to report $-0.38 EPS on March, 20.They anticipate $0.00 EPS change or 0.00 % from last quarter's $-0.38 EPS.
more»06:37 | 3/3/18
The Ledger Gazette
Arbutus Biopharma logo Hudson Bay Capital Management LP lifted its holdings in shares of Arbutus Biopharma Corp (NASDAQ:ABUS) by 239.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and ...
more»01:33 | 2/3/18
Frisco Fastball
Analysts expect Arbutus Biopharma Corporation (NASDAQ:ABUS) to report $-0.38 EPS on March, 20.They anticipate $0.00 EPS change or 0.00 % from last quarter's $-0.38 EPS.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
| Code | Last | Change |
|---|
| COMP | 10,321 | 328 |  | 3.08% |
| DJI | 29,635 | 404 | | 1.34% |
| SP500 | 3,583 | 87 | | 2.37% |
| DAX | 12,438 | 82 | | 0.67% |
| FTSE | 7,488 | 5 | | 0.07% |
| NI225 | 22,420 | 408 | | 1.86% |
| TWI | 67.27 | 0.00 |  | 0.00% |